GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Seed Co 7743.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

786

0.00%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Seed Co

Its shares trade on Tokyo Stock Exchange under the ticker 7743.T. It has been listed since 4 December 1989. In the fiscal year to 31 March 2026, it reported revenue of ¥33.94bn and net income of ¥1.14bn. At that date it held total assets of ¥62.50bn and shareholders' equity of ¥19.27bn.

Seed Co., Ltd. engages in the research, development, manufacture, and sale of contact lenses, lens care products, and eyeglasses. The company is headquartered in Chiyoda-Ku, Tokyo-To. is mainly engaged in the research, development, manufacture and sale of contact lenses. The firm operates in two business segments. The Contact Lens and Care Products segment provides contact lenses such as hard, soft and disposable lenses, as well as care products such as preservation solutions, cleansing solutions, enzyme cleaning solutions, disinfectant solutions and cases for contact lenses, among others. The Glasses segment is engaged in the sales of eyeglass frame and eyeglass fixtures. The firm is also engaged in intraocular lens and other business.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
4 Dec 1989
Employees
974
Website
seed.co.jp ↗

Leadership

Pay as last reported

  • Mr. Masahiro UrakabePresident, Chief Executive Officer, Representative Director, since 2009
  • Mr. Tetsuya SugiyamaSenior Managing Executive Officer, Chief Director of Administration, Director of Accounting, Director, since 2017
  • Mr. Jun IgarashiManaging Executive Officer, Chief Director of Sales, Director, since 2014
  • Mr. Takeshi FukudaManaging Executive Officer, Chief Director of Production Technology, Director, since 2013
  • Mr. Takao SatoManaging Executive Officer, Chief Director of Research & Development, Director of Development, Director, since 2014
  • Mr. Seiji HashimotoExecutive Officer, Director in charge of Overseas Sales
  • Mr. Takashi SaitoExecutive Officer, Chief Director of International Business, Director of Overseas Sales
  • Mr. Takanori YasudaExecutive Officer, Director of Eye Care Sales in Sales Unit, since 2022
  • Mr. Takahiro NakajimaExecutive Officer, Director of Human Resources and Education in Administration Unit
  • Mr. Kikue NakamuraExecutive Officer, Director of Academic Affairs, Director
  • Mr. Tomonori AkutsuExecutive Officer, Chief Director of Merchandise, Director of Logistics Management
  • Mr. Takeshi IshikawaExecutive Officer, Director of Business Planning

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Company has a long history with IPO in 1989
  • Operates in two business segments: Contact Lens and Care Products, and Glasses
  • Headquartered in Chiyoda-ku, Tokyo-To with 974 employees

Weaknesses

  • No specific weaknesses mentioned in the provided information
  • Limited to health care sector with focus on contact lenses and eyewear
  • No mention of financial performance or market share data

Opportunities

  • Expansion into intraocular lens and other business areas
  • Growth potential in contact lens and eyewear markets
  • Potential for international market expansion

Threats

  • Competition in the health care sector
  • Dependence on specific product lines like contact lenses
  • No information on market trends or regulatory challenges

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.